Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Ruby Khatun Khatun
    Ruby Khatun Khatun
      • Home
      • Ruby Khatun Khatun

      Articles By : Ruby Khatun Khatun

      USFDA lifts import alert on Divis Labs Vizag unit

      USFDA lifts import alert on Divis Labs Vizag unit

      Ruby Khatun Khatun16 Nov 2017 11:01 AM IST
      New Delhi: Drug firm Divis Laboratories on Wednesday said the US health regulator has lifted import alert imposed on its unit at Visakhapatnam.Last...
      Sun Pharma Q2 net profit dives 59 percent at Rs 912.12 crore

      Sun Pharma Q2 net profit dives 59 percent at Rs 912.12 crore

      Ruby Khatun Khatun16 Nov 2017 10:15 AM IST
      New Delhi: Pharma major Sun Pharmaceutical Industries reported a 59.19 percent dip in consolidated net profit to Rs 912.12 crore for the quarter ended...
      DRL launches anti-cancer drug in US market

      DRL launches anti-cancer drug in US market

      Ruby Khatun Khatun16 Nov 2017 10:01 AM IST
      New Delhi: Dr. Reddy's Laboratories Ltd (DRL) announced that it has launched Clofarabine Injection, a therapeutic equivalent generic version of Clolar...
      AstraZeneca gets FDA approval for asthma drug

      AstraZeneca gets FDA approval for asthma drug

      Ruby Khatun Khatun16 Nov 2017 10:00 AM IST
      AstraZeneca and its global biologics research and development arm, MedImmune, announced that the US Food and Drug Administration (FDA) has approved...
      Max Bupa introduces AnyTimeHealth machines

      Max Bupa introduces AnyTimeHealth machines

      Ruby Khatun Khatun16 Nov 2017 9:46 AM IST
      New Delhi: Max Bupa announced the launch of Max Bupa AnyTimeHealth (ATH) machines to propel health insurance penetration in the country.The ATH is Max...
      Cost of diabetes epidemic reaches 850 billion dollars a year

      Cost of diabetes epidemic reaches 850 billion dollars a year

      Ruby Khatun Khatun16 Nov 2017 9:32 AM IST
      The number of people living with diabetes has tripled since 2000, pushing the global cost of the disease to $850 billion a year, medical experts said...
      Janssen drops US lawsuit against Samsung Bioepis Remicade copy

      Janssen drops US lawsuit against Samsung Bioepis Remicade copy

      Ruby Khatun Khatun16 Nov 2017 9:15 AM IST
      SEOUL: A unit of healthcare conglomerate Johnson & Johnson has dropped a lawsuit it filed to block a copy of its rheumatoid arthritis drug...
      Fortis Healthcare board clears RHT portfolio acquisition for Rs 4,650 crore

      Fortis Healthcare board clears RHT portfolio acquisition for Rs 4,650 crore

      Ruby Khatun Khatun15 Nov 2017 2:09 PM IST
      New Delhi: Fortis Healthcare board has approved the proposed acquisition of the entire portfolio of Singapore-listed RHT Health Trust (RHT) for an...
      Malvinder Singh quits Religare, Co appoints former Home Secretary Lakshminarayanan as chairman

      Malvinder Singh quits Religare, Co appoints former Home Secretary Lakshminarayanan as chairman

      Ruby Khatun Khatun15 Nov 2017 12:55 PM IST
      New Delhi: Financial Services firm Religare Enterprises appointed former Home Secretary S Lakshminarayanan as executive chairman as part of major...
      FDA approves first drug in US with digital ingestion tracking

      FDA approves first drug in US with digital ingestion tracking

      Ruby Khatun Khatun15 Nov 2017 10:45 AM IST
      The U.S. Food and Drug Administration (FDA) approved the first drug in the U.S. with a digital ingestion tracking system. Abilify MyCite (aripiprazole...
      Bill Gates makes 100 million dollars personal investment to fight Alzheimer

      Bill Gates makes 100 million dollars personal investment to fight Alzheimer

      Ruby Khatun Khatun15 Nov 2017 10:25 AM IST
      LONDON: Billionaire Microsoft co-founder Bill Gates is to invest $50 million in the Dementia Discovery Fund, a venture capital fund that brings...
      Cadila Healthcare Q2 net profit up 32 percent at Rs 503 crore

      Cadila Healthcare Q2 net profit up 32 percent at Rs 503 crore

      Ruby Khatun Khatun15 Nov 2017 10:00 AM IST
      New Delhi: Drug firm Cadila Healthcare reported a 32.48 percent rise in its consolidated net profit to Rs 503.3 crore for the second quarter ended...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok